S. 4566: Increasing Access to Lung Cancer Screening Act

This bill, titled the "Increasing Access to Lung Cancer Screening Act," introduces several amendments to the Social Security Act to enhance lung cancer screening and tobacco cessation support under the Medicaid program and other health plans.

1. Medicaid Coverage for Lung Cancer Screening

The bill mandates that State Medicaid plans must cover annual lung cancer screenings without any cost-sharing for individuals who meet certain criteria. Specifically, it targets individuals for whom screening is recommended according to the guidelines set by the U.S. Preventive Services Task Force (USPSTF). The main points include:

• Inclusion of lung cancer screening as a covered service for qualifying individuals.
• No prior authorization is required before individuals can receive screening services.
• The bill specifies that the guidelines for screening must not reduce the frequency or eligibility of individuals recommended for screening as per the March 9, 2021, guidelines by the USPSTF.

2. Tobacco Cessation Services Coverage

The legislation expands coverage under Medicaid for counseling and pharmacotherapy aimed at helping individuals quit tobacco use. Changes in this section include:

• Removing restrictions related to pregnant women, thereby allowing all Medicaid recipients access to tobacco cessation services.
• Eliminating prior authorization requirements for accessing these services.

3. Implementation Timeline

The provisions of this bill will apply to items and services provided on or after January 1, 2028. However, states may have additional time if specific state legislation is required to comply with the new rules.

4. Medicare and Private Health Insurance Provisions

The bill also extends similar protections to Medicare and private health insurance plans, ensuring that:

• Annual lung cancer screenings recommended by the Secretary of Health and Human Services will not require prior authorization.
• Health plans must cover these screenings without imposing prior authorization requirements.

5. Education and Outreach Campaign

The Secretary of Health and Human Services is tasked with conducting a public education campaign to:

• Raise awareness about the importance of lung cancer screenings.
• Guide individuals on who should receive such screenings.

The campaign will be funded with an allocation of $10 million per fiscal year from 2028 through 2032.

6. Reporting Requirements

Within one year of the bill's enactment, the Comptroller General of the United States will conduct a study and report on the demographics of individuals diagnosed with lung cancer and those who are screened. The report will focus on:

• Identifying populations diagnosed with lung cancer that might not be covered under current screening guidelines.
• Providing recommendations for improving lung cancer screening among these groups.

Relevant Companies

• PFE - Pfizer Inc.: The changes in lung cancer screening coverage could affect the demand for drugs and treatments related to lung cancer, services that Pfizer offers.
• NVS - Novartis AG: This company may also see changes in market demand for its lung cancer therapies in light of increased screenings and awareness.